Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals

Ahmed Al-Ogaili1, Michaella Alexandrou1, Athanasios Rempakos1

  • 1Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Insights

Retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) using ipsilateral epicardial collaterals (IEC) shows similar success rates but increased complications compared to other collateral types.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Coronary Artery Disease

Background:

  • Limited data exists on retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) utilizing ipsilateral epicardial collaterals (IEC).
  • Understanding the feasibility and outcomes of IEC in retrograde CTO PCI is crucial for expanding treatment options.

Purpose of the Study:

  • To compare the clinical, angiographic characteristics, and outcomes of retrograde CTO PCI via IEC versus other collateral pathways.
  • To evaluate the safety and efficacy of using IEC for complex coronary interventions.

Main Methods:

  • An observational cohort study utilizing data from the Prospective Global registry for the study of Chronic Total Occlusion Intervention (PROGRESS-CTO).
  • Analysis of 4466 retrograde CTO PCI cases, with a specific focus on 191 cases using IEC.
  • Comparison of procedural success, technical success, and complication rates between IEC and non-IEC collateral groups.

Main Results:

  • Wiring success for IEC was 50%. The left circumflex artery was the most common target in the IEC group.
  • Technical (76% vs. 79%) and procedural success rates (74% vs. 79%) were comparable between IEC and other collateral groups.
  • IEC cases exhibited a significantly higher rate of periprocedural complications (25.8% vs. 16.4%), including perforations and pericardiocentesis.

Conclusions:

  • Retrograde CTO PCI via IEC achieves similar technical and procedural success rates as other collateral approaches.
  • The use of IEC is associated with a higher incidence of periprocedural complications, necessitating careful consideration and technique.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659